Emyria’s first Victorian Empax clinic operational with first treatments underway as targeted in Q2 CY26 Purpose-built, three-bed clinic established within Avive’s Mornington Peninsula Private Hospital ...

NEW YORK, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence Biomed" or the "Company") today announced the recruitment of Perth, Australia-based Empax Center as the ...

BRISBANE, Australia, Aug. 13, 2025 /PRNewswire/ -- Avive Health ("Avive"), an Australian-owned private mental health provider, has announced a major national partnership with Emyria Limited (ASX: EMD) ...

Benefits expected from H2 CY26 following final TGA endorsement, workforce planning, recruitment and training Special Report: ...

Emyria’s first Victorian-based Empax clinic on track to provide first patient treatments in Q2 2026 31 Victorian therapists contracted and trained, with four psychiatrists on the Authorised Prescriber ...

Emyria is among ASX healthcare companies securing government and insurer support to unlock predictable, scalable revenue ...

Special Report: Emyria has reported progress across its national Empax clinic rollout in its March quarter update, highlighting ongoing development of its clinical network, insurer-funded activity and ...

Trading on the Frankfurt Open Market broadens investor access and international visibility Special Report: Emyria has reported progress across its national Empax clinic rollout in its March quarter ...